Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
Genomic Health, Inc. today announced results from nine studies utilizing the Oncotype DX® test in early-stage breast cancer patients at the 12th Annual St. Gallen International Breast Cancer Conference in St.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Information Tags: breast, cancer, demonstrating, DX®, Genomic, health, international, Multiple, Oncotype, presents, Studies, test, Value, worldwide
Studies necessary for the treatment of cancer No. 1,Dr. Donato Perez Garcia MD,IPTLD
Dr. Donato Perez Garcia MD,IPTLD Alternative Cancer Treatment www.alternative-treatment.net MexDoctors.com http “La Ventana del Mundo a su Salud”
Categories: Breast Cancer Treatment Tags: 1Dr., cancer, Donato, Garcia, MDIPTLD, Necessary, Perez, Studies, Treatment
US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of …
US Oncology Research Investigators Participated in Studies That Will be Presented at the 2010 American Society of …
US Oncology, Inc., the nation’s leading integrated oncology company, announced today that three investigators affiliated with US Oncology Research participated in studies that will be presented orally at the 52nd American Society of Hematology Annual Meeting and Exposition at the Orange County Convention Center in Orlando, Fla.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Information Tags: 2010, American, Investigators, Oncology, Participated, presented, research, society, Studies
PGxHealth presents results from studies using FAMILION genetic testing at 2010 AHA
PGxHealth presents results from studies using FAMILION genetic testing at 2010 AHA
Clinical Data, Inc., today announced that results of studies using its FAMILION® genetic testing were presented at the 2010 American Heart Association (AHA) meeting. PGxHealth, a division of Clinical Data, together with its collaborators, presented results from the largest, most comprehensive studies of genetic variation associated with certain cardiac conditions that were revealed using …
Read more on News-Medical-Net
Categories: Breast Cancer Doctors Tags: 2010, FAMILION, From, Genetic, PGxHealth, presents, Results, Studies, testing, Using
Radiation, Risks Are Focus of Breast Screening Studies
Radiation, Risks Are Focus of Breast Screening Studies
Doctors have expressed concerns about relying too much on breast imaging exams that expose women to far higher doses of radiation than regular mammography.
Read more on New York Times
Roche’s Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Roche’s Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Roche Holding AG’s top-seller Avastin didn’t slow breast tumors in new studies as much as in earlier data used to win approval, according to U.S. regulators weighing whether to permit continued sales for this use.
Read more on Bloomberg
Categories: Breast Cancer Chemotherapy Tags: Avastin, Data, early, good, Roche's, says, showed, Studies
Can occupational exposure to chemo cause cancer? Studies point in that direction
Can occupational exposure to chemo cause cancer? Studies point in that direction
Sue Crump braced as the chemo drugs dripped into her body. She knew treatment would be rough. She had seen its signature countless times in the ravaged bodies and hopeful faces of cancer patients in hospitals where she had spent 23 years mixing chemo as a pharmacist.
Read more on St. Louis Beacon
Categories: Breast Cancer Information Tags: cancer, cause, chemo, direction, exposure, occupational, point, Studies
Cellceutix Completes All Three Animal Safety Pharmacology Studies for Its Cancer Compound Required by FDA Prior to …
Cellceutix Completes All Three Animal Safety Pharmacology Studies for Its Cancer Compound Required by FDA Prior to …
BEVERLY, MA–(Marketwire – 07/07/10) – Cellceutix Corporation (OTC.BB: CTIX – News ) today announced that it has completed all three animal safety pharmacology studies for its cancer compound, Kevetrin, that are required by the U. S. Food and Drug Administration prior to filing an IND. These studies involve assessments of the impact of the administration of a compound on the respiratory …
Read more on Marketwire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: animal, cancer, Cellceutix, Completes, compound, Pharmacology, prior, required, Safety, Studies, three
Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual …
Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual …
Huntington Beach, California and Amsterdam, June 4, 2010 (ots/PRNewswire) – Agendia, a world leader in molecular cancer diagnostics, today announced that …
Read more on FinanzNachrichten
Categories: Breast Cancer Doctors Tags: 2010, Agendia, annual, Array, ASCO, breast, Broad, cancers, Colorectal, Predictive, presents, Prognostic, Studies
Studies Confirm Link Between Breast Density and Cancer
Studies Confirm Link Between Breast Density and Cancer
WEDNESDAY, April 21 (HealthDay News) — Having dense breasts has long been known to increase a woman’s risk for breast cancer, and new research confirms that a decline in breast density over time does, in fact, decrease that risk.
Read more on HealthDay via Yahoo! News
